MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-16-2023
Athersys EV/EBITDA Ratio 2011-2026 | ATHX
Annual EV/EBITDA Ratio Athersys
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.437 | -4.03 | -3.93 | -6.59 | -5.25 | -5.4 | -4.34 | -4.71 | -7.96 | -1.29 | -2.55 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.437 | -7.96 | -4.15 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M |  Germany |
 |
Aclaris Therapeutics
ACRS
|
-9.24 | $ 2.68 | - | $ 207 M |  USA |
 |
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 3.21 | - | $ 7.72 B |  Australia |
 |
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | USA |
 |
Ascendis Pharma A/S
ASND
|
-15.7 | $ 213.28 | - | $ 5 B |  Danmark |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
-1.38 | $ 1.95 | - | $ 498 M |  Britain |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M |  France |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | USA |
 |
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | USA |
 |
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | Britain |
 |
Aravive
ARAV
|
-0.158 | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-9.01 | - | -6.81 % | $ 3.04 B | USA |
 |
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M | USA |
 |
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - |  Russia |
 |
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-12.7 | - | -15.15 % | $ 60.3 M | Britain |
 |
BioNTech SE
BNTX
|
4.1 | $ 100.08 | - | $ 27.2 B | Germany |
 |
BioDelivery Sciences International
BDSI
|
8 | - | -4.8 % | $ 255 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
17.3 | $ 27.33 | -1.05 % | $ 1.32 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 4.71 | -0.21 % | $ 10.2 B |  Israel |
 |
AVROBIO
AVRO
|
0.957 | - | 1083.1 % | $ 745 M | USA |
 |
Catalyst Biosciences
CBIO
|
0.34 | $ 10.94 | -1.17 % | $ 720 M | USA |
 |
BeiGene, Ltd.
BGNE
|
-208 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-14.9 | $ 11.74 | - | $ 759 M | USA |
 |
BioVie
BIVI
|
-0.244 | $ 1.35 | -2.88 % | $ 1.99 M | USA |
 |
Axon Enterprise
AXON
|
-63.9 | $ 620.91 | - | $ 47 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
-1.92 | $ 2.83 | - | $ 17.8 M | USA |
 |
AstraZeneca PLC
AZN
|
76.5 | $ 95.16 | - | $ 96.9 B | Britain |
 |
Bellicum Pharmaceuticals
BLCM
|
1.13 | - | -9.72 % | $ 5.89 M | USA |
 |
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | USA |
 |
Berkeley Lights
BLI
|
-16.9 | - | -7.31 % | $ 87 M | USA |
 |
Brickell Biotech
BBI
|
0.668 | - | -5.38 % | $ 6.06 M | USA |
 |
bluebird bio
BLUE
|
-0.805 | - | - | $ 546 M | USA |
 |
Biogen
BIIB
|
12.7 | $ 186.91 | - | $ 27.2 B | USA |
 |
Abeona Therapeutics
ABEO
|
0.0546 | $ 5.22 | 1.16 % | $ 112 M | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
190 | $ 1.46 | 0.69 % | $ 16.7 M | Israel |
 |
Cellectis S.A.
CLLS
|
-1.37 | $ 4.55 | - | $ 116 M | France |